Metronidazole-triazole conjugates: Activity against Clostridium difficile and parasites

被引:43
作者
Jarrad, Angie M. [1 ]
Karoli, Tomislav [1 ]
Debnath, Anjan [2 ]
Tay, Chin Yen [4 ]
Huang, Johnny X. [1 ]
Kaeslin, Geraldine [1 ]
Elliott, Alysha G. [1 ]
Miyamoto, Yukiko [3 ]
Ramu, Soumya [1 ]
Kavanagh, Angela M. [1 ]
Zuegg, Johannes [1 ]
Eckmann, Lars [3 ]
Blaskovich, Mark A. T. [1 ]
Cooper, Matthew A. [1 ]
机构
[1] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia
[2] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Perth, WA 6099, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国惠康基金;
关键词
Nitroimidazole; Click chemistry; Antibiotic; Anaerobe; IN-VITRO; DRUG; RESISTANCE;
D O I
10.1016/j.ejmech.2015.06.019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Metronidazole has been used clinically for over 50 years as an antiparasitic and broad-spectrum antibacterial agent effective against anaerobic bacteria. However resistance to metronidazole in parasites and bacteria has been reported, and improved second-generation metronidazole analogues are needed. The copper catalysed Huigsen azide-alkyne 1,3-dipolar cycloaddition offers a way to efficiently assemble new libraries of metronidazole analogues. Several new metronidazole-triazole conjugates (Mtz-triazoles) have been identified with excellent broad spectrum antimicrobial and antiparasitic activity targeting Clostridium difficile, Entamoeba histolytica and Giardia lambda. Cross resistance to metronidazole was observed against stable metronidazole resistant C. difficile and G.. lamblia strains. However for the most potent Mtz-triazoles, the activity remained in a therapeutically relevant window. (C) 2015 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:96 / 102
页数:7
相关论文
共 30 条
[1]  
Abu S.E.A.M., 2009, Patent No. [EP2085394 A3, 2085394A3]
[2]  
[Anonymous], 2013, METH ANT DIL DISK SU
[3]   Emergence of reduced susceptibility to metronidazole in Clostridium difficile [J].
Baines, Simon D. ;
O'Connor, Rachael ;
Freeman, Jane ;
Fawley, Warren N. ;
Harmanus, Celine ;
Mastrantonio, Paola ;
Kuijper, Ed J. ;
Wilcox, Mark H. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :1046-1052
[4]   Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates [J].
Beena ;
Kumar, Nitin ;
Rohilla, Rajesh K. ;
Roy, N. ;
Rawat, Diwan S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (05) :1396-1398
[5]   ALTERED UPTAKE OF METRONIDAZOLE INVITRO BY STOCKS OF GIARDIA-INTESTINALIS WITH DIFFERENT DRUG SENSITIVITIES [J].
BOREHAM, PFL ;
PHILLIPS, RE ;
SHEPHERD, RW .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1988, 82 (01) :104-106
[6]   Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole [J].
Chong, Patrick M. ;
Lynch, Tarah ;
McCorrister, Stuart ;
Kibsey, Pamela ;
Miller, Mark ;
Gravel, Denise ;
Westmacott, Garrett R. ;
Mulvey, Michael R. .
PLOS ONE, 2014, 9 (01)
[7]  
Comer J.E. A., 2003, Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability (Methods and Principles in Medicinal Chemistry), V18, P21, DOI [10.1002/3527601473.ch2, DOI 10.1002/3527601473.CH2]
[8]   A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target [J].
Debnath, Anjan ;
Parsonage, Derek ;
Andrade, Rosa M. ;
He, Chen ;
Cobo, Eduardo R. ;
Hirata, Ken ;
Chen, Steven ;
Garcia-Rivera, Guillermina ;
Orozco, Esther ;
Martinez, Maximo B. ;
Gunatilleke, Shamila S. ;
Barrios, Amy M. ;
Arkin, Michelle R. ;
Poole, Leslie B. ;
McKerrow, James H. ;
Reed, Sharon L. .
NATURE MEDICINE, 2012, 18 (06) :956-+
[9]   SYNTHESIS OF N-ALKYLPYRAZOLES BY PHASE-TRANSFER CATALYSIS WITHOUT SOLVENT [J].
DIEZBARRA, E ;
DELAHOZ, A ;
SANCHEZMIGALLON, A ;
TEJEDA, J .
SYNTHETIC COMMUNICATIONS, 1990, 20 (18) :2849-2853
[10]   Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity [J].
Dingle, Kate E. ;
Griffiths, David ;
Didelot, Xavier ;
Evans, Jessica ;
Vaughan, Alison ;
Kachrimanidou, Melina ;
Stoesser, Nicole ;
Jolley, Keith A. ;
Golubchik, Tanya ;
Harding, Rosalind M. ;
Peto, Tim E. ;
Fawley, Warren ;
Walker, A. Sarah ;
Wilcox, Mark ;
Crook, Derrick W. .
PLOS ONE, 2011, 6 (05)